The two markers had a good diagnostic performance across the AD spectrum, with UCHL1 showing the best capability to differentiate early AD (both preclinical and mild cognitive impairment) from SCD and MCI subjects. The gene discussed is UCHL1; the disease is Cognitive impairment.